We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

59 hedge funds and large institutions have $30.5M invested in Actinium Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,361% more capital invested

Capital invested by funds: $2.09M → $30.5M (+$28.4M)

800% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 2

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

40% more funds holding

Funds holding: 42 → 59 (+17)

0.52% more ownership

Funds ownership: 0.22% → 0.73% (+0.52%)

Holders
59
Holders Change
+17
Holders Change %
+40.48%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
18
Reduced
2
Closed
3
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$9.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.59M
3
SCM
Sio Capital Management
New York
+$2.06M
4
BlackRock
BlackRock
New York
+$1.77M
5
CH
CVI Holdings
Delaware
+$720K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$14.6K
2
RJFSA
Raymond James Financial Services Advisors
Florida
-$8K
3
Jane Street
Jane Street
New York
-$3K
4
RJA
Raymond James & Associates
Florida
-$3K
5
Simplex Trading
Simplex Trading
Illinois
-$1.24K
Name Holding Trade Value Shares
Change 		Change in
Stake
SXL
26
Summit X LLC
Missouri
$24K +$3.96K +523 +30%
Barclays
27
Barclays
United Kingdom
$18K +$454 +60 +4%
DADC
28
D.A. Davidson & Co
Montana
$17K +$2.27K +300 +22%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$14K – – –
IB
30
Intrust Bank
Kansas
$14K – – –
FA
31
FCG Advisors
New Jersey
$13K – – –
TSS
32
Two Sigma Securities
New York
$13K +$5.95K +785 +172%
Carson Wealth (CWM LLC)
33
Carson Wealth (CWM LLC)
Nebraska
$12K – – –
Rockefeller Capital Management
34
Rockefeller Capital Management
New York
$12K +$2.64K +348 +42%
TRCT
35
Tower Research Capital (TRC)
New York
$12K +$8.79K +1,160 New
Morgan Stanley
36
Morgan Stanley
New York
$11K +$4.3K +568 +109%
LWM
37
Laidlaw Wealth Management
New York
$10K +$7.07K +933 New
DY
38
Dowling & Yahnke
California
$8K – – –
HFM
39
Hartford Financial Management
Connecticut
$6K – – –
OC
40
Oppenheimer & Co
New York
$5K – – –
SFWA
41
Summit Financial Wealth Advisors
Louisiana
$5K – – –
Wells Fargo
42
Wells Fargo
California
$5K – – –
Ameriprise
43
Ameriprise
Minnesota
$5K +$3.3K +436 New
WSFS
44
Wilmington Savings Fund Society
Delaware
$4K – – –
PAG
45
Private Advisor Group
New Jersey
$4K +$2.52K +333 New
CAN
46
Cetera Advisor Networks
California
$2K +$1.26K +167 New
TC
47
Truvestments Capital
Florida
$2K +$1.6K +211 New
IA
48
IFP Advisors
Florida
$1K – – –
Northwestern Mutual Wealth Management
49
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
TCOV
50
Trust Company of Vermont
Vermont
$1K – – –
1
2
3

ATNM Hedge Fund Activity: Q2 2020 in Review

59 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q2 2020, worth a combined $30.5M — up 1,361% from $2.09M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ATNM positions and 3 closed out — a net gain of 17 holders — while 18 added to existing stakes and 2 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $9.34M. The largest seller was UBS Group, cutting an estimated $14.6K.

  • 59 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q2 2020, up from 42 in Q1 2020.
  • Funds reported $30.5M of Actinium Pharmaceuticals stock for Q2 2020, up 1,361% quarter-over-quarter.
  • 20 funds opened new Actinium Pharmaceuticals positions in Q2 2020 and 3 closed out, a net change of +17 holders.
  • The largest Actinium Pharmaceuticals buyer in Q2 2020 was Consonance Capital Management, an estimated $9.34M added.
  • The largest Actinium Pharmaceuticals seller in Q2 2020 was UBS Group, an estimated $14.6K sold.

Based on aggregated 13F filings for Q2 2020.